Cargando…
Technology development of hyperthermic pressurized intraperitoneal aerosol chemotherapy (hPIPAC)
BACKGROUND: Optimized drug delivery systems are needed for intraperitoneal chemotherapy. The aim of this study was to develop a technology for applying pressurized intraperitoneal aerosol chemotherapy (PIPAC) under hyperthermic conditions (hPIPAC). METHODS: This is an ex-vivo study in an inverted bo...
Autores principales: | Bachmann, C., Sautkin, I., Nadiradze, G., Archid, R., Weinreich, F. J., Königsrainer, A., Reymond, M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523399/ https://www.ncbi.nlm.nih.gov/pubmed/34114069 http://dx.doi.org/10.1007/s00464-021-08567-y |
Ejemplares similares
-
Overcoming Drug Resistance by Taking Advantage of Physical Principles: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)
por: Nadiradze, Giorgi, et al.
Publicado: (2019) -
Comparison between microcatheter and nebulizer for generating Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
por: Toussaint, Laura, et al.
Publicado: (2020) -
Correction to: Comparison between microcatheter and nebulizer for generating Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)
por: Toussaint, Laura, et al.
Publicado: (2021) -
Staging laparoscopy and Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for peritoneal metastasis: safe access to the abdomen
por: Glatz, Torben, et al.
Publicado: (2019) -
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Girshally, Ramy, et al.
Publicado: (2016)